Chronic Lymphocytic Leukaemia
Pirtobrutinib Shows Promise as a Novel CLL/SLL Treatment for Patients Previously Treated with BTK Inhibitors
SG Tylor
Source – Eli Lilly On July 6, 2023, Eli Lilly and Company’s oncology unit announced that The New England Journal ...